Eyewire News: The Podcast - Eyewire News

Podcast details

Technical and general information from the podcast's RSS feed.

RSS

Apple

Recent rankings

Latest chart positions across Apple Podcasts and Spotify rankings.

Shared links between episodes and podcasts

Links found in episode descriptions and other podcasts that share them.

See all

RSS feed quality and score

Technical evaluation of the podcast's RSS feed quality and structure.

See all

Publication history

Monthly episode publishing history over the past years.

Latest published episodes

Recent episodes with titles, durations, and descriptions.

See all

Viridian Executive Discusses FDA Approval of New TED Therapy

Wednesday, July 1, 2026 • Duration 14:15

An executive from Viridian discusses the FDA approval of Lumvoa for thyroid eye disease (TED); a biosimilar referencing Lucentis is relaunched in the US; and Lumibird introduces a wireless integrated laser-indirect-ophthalmoscope. Learn more about your ad choices. Visit megaphone.fm/adchoices

Read moreCollapse

Ocular Updates Plans for Axpaxli NDA for Wet AMD

Wednesday, June 24, 2026 • Duration 06:37

Ocular Therapeutix provides a key update on its NDA plans for wet AMD drug candidate Axpaxli; Thea US launches a first-of-its-kind eye gel for glaucoma; and there were several recent milestones reached in the clinical development of novel drugs for a variety of ocular conditions. Learn more about your ad choices. Visit megaphone.fm/adchoices

Read moreCollapse

Tecnis PureSee IOL Fully Launched in the US

Wednesday, June 17, 2026 • Duration 06:44

Johnson & Johnson expands the availability of its latest Tecnis lens; Bayer completes its acquisition of Perfuse Therapeutics, expanding its presence in ophthalmology; and ophthalmic leaders discuss how to navigate the current regulatory environment of the FDA. Learn more about your ad choices. Visit megaphone.fm/adchoices

Read moreCollapse

Study Examines Semaglutide and Wet AMD Risk

Wednesday, June 10, 2026 • Duration 04:39

An international study examines the link between a popular weight loss medication and wet AMD risk; Heidelberg receives FDA clearance for a Spectralis software upgrade; and Bausch + Lomb launches its latest over-the-counter dry eye relief product in the US. Learn more about your ad choices. Visit megaphone.fm/adchoices

Read moreCollapse

Oculis Announces Phase 3 Results for DME Eye Drops

Wednesday, June 3, 2026 • Duration 04:51

Oculis Releases phase 3 data for its investigational eye drop for DME; Rayner expands its surgical offerings with the launch of a new OVD; and a biosimilar referencing Eylea is launched in Europe. Learn more about your ad choices. Visit megaphone.fm/adchoices

Read moreCollapse

Outlook Wins Appeal for Wet AMD Drug Candidate Lytenava

Wednesday, May 27, 2026 • Duration 04:31

Outlook Therapeutics takes a major step forward in its plan to gain approval for wet AMD drug Lytenava; the first commercial FLIGHT procedures using the ViaLuxe Laser System are performed in Europe; and Oculus introduces a new AI-assisted tool designed to help clinicians evaluate MGD using meibography images. Learn more about your ad choices. Visit megaphone.fm/adchoices

Read moreCollapse

Next-Generation FSYX Goggles Approved for Glaucoma

Wednesday, May 20, 2026 • Duration 08:06

The FDA approves wireless pressure-modulating goggles for at-home glaucoma treatment; Bausch + Lomb launches a new PreserVision AREDS eye vitamin formation; and an Executive Strategic Advisor discusses the regulation environment for communication in eye care. Learn more about your ad choices. Visit megaphone.fm/adchoices

Read moreCollapse

Future of Posterior Therapeutics

Wednesday, May 13, 2026 • Duration 10:58

Leading ophthalmologists join us to discusses the hottest topics in the posterior segment treatment landscape. Learn more about your ad choices. Visit megaphone.fm/adchoices

Bayer Acquires Perfuse in $2.45 Billion Deal

Wednesday, May 6, 2026 • Duration 06:50

Bayer expands ophthalmology pipeline with acquisiton of Perfuse Therapeutics; Viridian announces new phase 3 data for its investigational subcutaneous injection for chronic thyroid eye disease; and Steven Dell, MD discusses the impact of declining reimbursement could on ophthalmic practices. Learn more about your ad choices. Visit megaphone.fm/adchoices

Read moreCollapse

How Ophthalmology Strategics are Rewriting the Playbook

Wednesday, April 29, 2026 • Duration 06:10

Ophthalmic executives discuss strategies to scale and grow in today’s economic and regulatory environments. Learn more about your ad choices. Visit megaphone.fm/adchoices

Eyewire News: The Podcast – Details, episodes & analysis

Podcast details

Recent rankings

Apple Podcasts

Spotify

Shared links between episodes and podcasts

RSS feed quality and score

Publication history

Latest published episodes

Related Shows Based on Content Similarities

Related Shows Based on Content Similarities

Apple Podcasts

Spotify

Eyewire News: The Podcast – Details, episodes & analysis

Podcast details

Recent rankings

Apple Podcasts

Spotify

Shared links between episodes and podcasts

RSS feed quality and score

Publication history

Latest published episodes

Similar podcasts and content

Related Shows Based on Content Similarities

Related Shows Based on Content Similarities

Apple Podcasts

Spotify